Kelly G E, Scheibner A, Sheil A G
Immunol Cell Biol. 1987 Apr;65 ( Pt 2):153-61. doi: 10.1038/icb.1987.17.
The effects of ultraviolet irradiation (UVI) (290-400 nm) and/or systemic immunosuppressive drug therapy (azathioprine and prednisolone) on the immunocompetence of the skin of hairless (HRA/Skh-1) mice were investigated. Mice were studied for the density of ATPase+, Ia+ and Thyl X 2+ cells in the dorsal epidermis and contact hypersensitivity (CH) of skin to dinitrofluorobenzene (DNFB). Prednisolone therapy alone and UVI alone each reduced the densities of the three skin immune cell markers and CH responsiveness; azathioprine therapy alone had no such effects. When a suberythemal dose of UVI that induced a moderately depressive effect on these two skin parameters was used, additional azathioprine therapy produced no further depression; additional prednisolone therapy further depressed the densities of ATPase+ and Ia+ cells and CH responsiveness; additional therapy with combined azathioprine and prednisolone induced profound depression of the incidences of the three immune cell markers and of CH responsiveness. These data point to interaction between azathioprine/prednisolone therapy and UVI in depressing local immune function within skin which may contribute to the increased susceptibility of the sun-exposed skin of immunosuppressed kidney transplant recipients to infective and carcinogenic processes.
研究了紫外线照射(UVI)(290 - 400纳米)和/或全身免疫抑制药物治疗(硫唑嘌呤和泼尼松龙)对无毛(HRA/Skh-1)小鼠皮肤免疫能力的影响。研究了小鼠背部表皮中ATP酶阳性、Ia阳性和Thyl X 2阳性细胞的密度以及皮肤对二硝基氟苯(DNFB)的接触性超敏反应(CH)。单独使用泼尼松龙治疗和单独使用UVI均降低了三种皮肤免疫细胞标志物的密度和CH反应性;单独使用硫唑嘌呤治疗则无此效果。当使用对这两个皮肤参数产生中度抑制作用的亚红斑剂量UVI时,额外的硫唑嘌呤治疗未产生进一步的抑制作用;额外的泼尼松龙治疗进一步降低了ATP酶阳性和Ia阳性细胞的密度以及CH反应性;联合使用硫唑嘌呤和泼尼松龙的额外治疗导致三种免疫细胞标志物的发生率和CH反应性显著降低。这些数据表明,硫唑嘌呤/泼尼松龙治疗与UVI在抑制皮肤局部免疫功能方面存在相互作用,这可能导致免疫抑制的肾移植受者暴露于阳光下的皮肤对感染和致癌过程的易感性增加。